Hyperreactivity by an enhancement of the arachidonate pathway of platelets treated with cholesterol-rich phospholipid-dispersions.
D001095:Arachidonic Acids / Q000378:metabolism*; D001241:Aspirin / Q000494:pharmacology; D001792:Blood Platelets / Q000187:drug effects*; D002462:Cell Membrane / Q000187:drug effects; D002784:Cholesterol / Q000494:pharmacology*; D006801:Humans; D007213:Indomethacin / Q000494:pharmacology; D008315:Malondialdehyde / Q000096:biosynthesis; D010743:Phospholipids / Q000494:pharmacology*; D010974:Platelet Aggregation / Q000187:drug effects; D012701:Serotonin / Q000502:physiology; D013997:Time Factors
D001095:Arachidonic Acids; D010743:Phospholipids; D012701:Serotonin; D008315:Malondialdehyde; D002784:Cholesterol; D001241:Aspirin; D007213:Indomethacin